News – Page 1103 – Endpoints News

After jumping ship at Eli Lilly, Politico reports Alex Azar may soon land top HHS job

8 years ago

Boston biotech recruits Sanofi’s US cancer research chief; Syndax in-licenses Allergan portfolio

8 years ago

Pfizer, NEA back Cydan II's plans to launch a fresh slate of biotech startups focused on rare genetic diseases

8 years ago

Takeda is beefing up its NASH pipeline with a $470M discovery deal with HemoShear

8 years ago

Cascade of costs could push CAR-T therapy to $1.5M per patient

8 years ago

Orexigen posts a ‘for sale’ sign in the yard as weak Contrave sales raise concerns

8 years ago

J&J is jettisoning two of its promised blockbuster drugs, and it couldn't come at a worse time

8 years ago

Armed with $42.5M, Gemini embraces the Goldilocks strategy in bringing precision med to AMD

8 years ago

Allergan slammed as federal judge invalidates Restasis patents, slaps Mohawk deal

8 years ago

R&D trend #5: The top execs in biotech are riding a boom — but there’s one big step left

8 years ago

Exelixis shares surge on positive liver cancer results; Ramaswamy’s Myovant banks $140M for PhIII

8 years ago

FDA gives Novo Nordisk top grades for its diabetes drug semaglutide, but retinopathy remains key

8 years ago

After getting skunked by rivals, Pfizer touts ‘breakthrough’ cancer drug lorlatinib, heads to the FDA

8 years ago

Racing against Alnylam, Ionis posts positive PhIII ATTR efficacy numbers, but questions linger

8 years ago

EMA counters the academics who criticized the cancer drug approval process

8 years ago

Roche ties a $387M knot with Warp Drive Bio in collaboration spotlighting new classes of antibiotics

8 years ago

FDA experts give a thumbs-up to Aerie Pharma’s glaucoma drug

8 years ago

That $1.25B Bristol-Myers IDO1 drug? Incyte claims a former staffer stole it

8 years ago

OptiNose joins the biotech IPO fiesta, raises $120M in upsized offering

8 years ago

Ionis launches an early-stage tau drug study for Alzheimer’s, picking up $10M from Biogen

8 years ago

Biotech entrepreneur Saurabh Saha moves to translational research chief at Bristol-Myers; Ex-GSK pharma chief Hussain ...

8 years ago

Lupin is prepping a $1B US deal spree; Protagonist raising $60M for trial work

8 years ago

Four years after it imploded at Sanofi, John Hood is resurrecting the myelofibrosis drug fedratinib

8 years ago

Bain, RA back InflaRx’s $55M round after early study produces promising results

8 years ago

First page Previous page 1100 1101 110211031104 1105 1106 Next page Last page